Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Clinical trial NCT03882437 · UNKNOWN
Trial details
- NCT number
- NCT03882437
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-17
- Primary completion
- 2025-03-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.